Filing Details

Accession Number:
0000911916-17-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-05 16:35:03
Reporting Period:
2017-01-03
Filing Date:
2017-01-05
Accepted Time:
2017-01-05 16:35:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348649 Colucid Pharmaceuticals Inc. CLCD Pharmaceutical Preparations (2834) 203419541
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1639972 C. Linda Hogan C/O Colucid Pharmaceuticals, Inc.
222 Third Street
Cambridge MA 02142
Head, Bus. Dev. And Strategy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-03 718 $6.75 718 No 4 M Direct
Common Stock Disposition 2017-01-03 718 $36.25 0 No 4 S Direct
Common Stock Acquisiton 2017-01-04 185 $7.56 185 No 4 M Direct
Common Stock Disposition 2017-01-04 185 $36.40 0 No 4 S Direct
Common Stock Acquisiton 2017-01-05 1,677 $10.00 1,677 No 4 M Direct
Common Stock Disposition 2017-01-05 477 $33.55 1,200 No 4 S Direct
Common Stock Disposition 2017-01-05 600 $34.40 600 No 4 S Direct
Common Stock Disposition 2017-01-05 600 $35.61 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-01-03 718 $0.00 718 $6.75
Common Stock Stock Option (Right to Buy) Disposition 2017-01-04 185 $0.00 185 $7.56
Common Stock Stock Option (Right to Buy) Disposition 2017-01-05 1,677 $0.00 1,677 $10.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,594 2026-03-04 No 4 M Direct
5,741 2025-08-04 No 4 M Direct
46,966 2025-05-05 No 4 M Direct
Footnotes
  1. Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016.
  2. Represents the sale of 477 shares in multiple transactions, ranging in price from $33.40 to $34.00 per share, resulting in a weighted average sale price of $33.5548. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  3. Represents the sale of 600 shares in multiple transactions, ranging in price from $35.60 to $35.65 per share, resulting in a weighted average sale price of $35.6083. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  4. Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.
  5. Options vest as follows: one-third of the shares vested on August 4, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.
  6. Options vest as follows: 33% of the shares vested on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.